Rici Healthcare Holdings Limited (1526.HK)
ValueMarkers Composite Index
85% below intrinsic value ($1)
Rici Healthcare Holdings Limited (1526.HK) — VMCI valuation read
Headline read on 1526.HK: VMCI of 63/100 versus a Healthcare sector median of 50. The 13-point above-median position is what makes Rici Healthcare Holdings Limited a relative-value candidate in the mid-cap cohort, before any pillar-level review.
Form 4 filings on 1526.HK: zero in the trailing 30 days. The absence of insider transactions is itself a data point, just a low-information one. The thesis runs on financials and price action until that changes.
**Investor frame.** Three reads on 1526.HK: value (1526.HK trades at 23.0x earnings, 28% above the Healthcare median of 18.0x), quality (ROIC of 15.0% sits 5.0pp above the Healthcare median (10.0%)), and risk (net debt to EBITDA of 2.5x is the rate-sensitivity line to watch). The value read also implies an EV/EBITDA gap of +4.0x against the Healthcare 12.0x baseline.
1526.HK rose 3.4% over the trailing 7 days, with a +2.4% read on a 30-day basis.
Rici Healthcare Holdings Limited, an investment holding company, operates general and specialty hospitals, medical examination centers, and clinics in the People's Republic of China. As of December 31, 2021, the company had 68 medical examination centers. It also offers health counseling, nursing, diagnosis, and lease services. The company was founded in 2000 and is headquartered in Shanghai, the People's Republic of China.
Related Stocks in Healthcare
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.